Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/56159
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Barter, Philip John | en |
dc.date.issued | 2005 | en |
dc.identifier.citation | American Journal of Cardiology, 2005; 95(2):194-198 | en |
dc.identifier.issn | 0002-9149 | en |
dc.identifier.uri | http://hdl.handle.net/2440/56159 | - |
dc.description | Copyright © 2004 Excerpta Medica Inc. All rights reserved. | en |
dc.description.statementofresponsibility | Diego F. Wyszynski, Dawn M. Waterworth, Philip J. Barter, Jonathan Cohen, Y. Antero Kesäniemi, Robert W. Mahley, Ruth McPherson, Gérard Waeber, Thomas P. Bersot, Sanjay S. Sharma, Vikki Nolan, Lefkos T. Middleton, Scott S. Sundseth, Lindsay A. Farrer, Vincent Mooser, Scott M. Grundy | en |
dc.language.iso | en | en |
dc.publisher | Excerpta Medica | en |
dc.title | Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project) | en |
dc.type | Journal article | en |
dc.contributor.school | School of Medicine | en |
dc.identifier.doi | 10.1016/j.amicard.2004.08.091 | en |
Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.